Asymmetrical dimethylarginine - The Uber marker?

被引:341
作者
Cooke, JP [1 ]
机构
[1] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA
关键词
arginine; nitric oxide synthase; endothelium; risk factors; amidohydrolases;
D O I
10.1161/01.CIR.0000126823.07732.D5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1813 / 1818
页数:6
相关论文
共 82 条
  • [1] Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus
    Abbasi, F
    Asagmi, T
    Cooke, JP
    Lamendola, C
    McLaughlin, T
    Reaven, GM
    Stuehlinger, M
    Tsao, PS
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (10) : 1201 - +
  • [2] Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase
    Achan, V
    Broadhead, M
    Malaki, M
    Whitley, G
    Leiper, J
    MacAllister, R
    Vallance, P
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (08) : 1455 - 1459
  • [3] all-trans-retinoic acid increases nitric oxide synthesis by endothelial cells -: A role for the induction of dimethylarginine dimethylaminohydrolase
    Achan, V
    Tran, CTL
    Arrigoni, F
    Whitley, GSJ
    Leiper, JM
    Vallance, P
    [J]. CIRCULATION RESEARCH, 2002, 90 (07) : 764 - 769
  • [4] Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease
    Adams, MR
    McCredie, R
    Jessup, W
    Robinson, J
    Sullivan, D
    Celermajer, DS
    [J]. ATHEROSCLEROSIS, 1997, 129 (02) : 261 - 269
  • [5] Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
    Al Suwaidi, J
    Hamasaki, S
    Higano, ST
    Nishimura, RA
    Holmes, DR
    Lerman, A
    [J]. CIRCULATION, 2000, 101 (09) : 948 - 954
  • [6] Metabolism of asymmetric dimethylarginines is regulated in the lung developmentally and with pulmonary hypertension induced by hypobaric hypoxia
    Arrigoni, FI
    Vallance, P
    Haworth, SG
    Leiper, JM
    [J]. CIRCULATION, 2003, 107 (08) : 1195 - 1201
  • [7] Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes
    Asagami, T
    Abbasi, F
    Stuelinger, M
    Lamendola, C
    McLaughlin, T
    Cooke, JP
    Reaven, GM
    Tsao, PS
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (07): : 843 - 846
  • [8] Endogenous nitric oxide synthase inhibitors in endothelial cells, endothelin-1 within the vessel wall, and intimal hyperplasia in perimenopausal human uterine arteries
    Beppu, M
    Obayashi, S
    Aso, T
    Goto, M
    Azuma, H
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2002, 39 (02) : 192 - 200
  • [9] Asymmetric dimethylarginine (ADMA):: A novel risk factor for endothelial dysfunction -: Its role in hypercholesterolemia
    Böger, RH
    Bode-Böger, SM
    Szuba, A
    Tsao, PS
    Chan, JR
    Tangphao, O
    Blaschke, TF
    Cooke, JP
    [J]. CIRCULATION, 1998, 98 (18) : 1842 - 1847
  • [10] An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes
    Böger, RH
    Bode-Böger, SM
    Tsao, PS
    Lin, PS
    Chan, JR
    Cooke, JP
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (07) : 2287 - 2295